View : 648 Download: 473

Full metadata record

DC Field Value Language
dc.contributor.author박상희*
dc.contributor.author안영호*
dc.date.accessioned2019-02-26T16:30:04Z-
dc.date.available2019-02-26T16:30:04Z-
dc.date.issued2019*
dc.identifier.issn1226-3613*
dc.identifier.issn2092-6413*
dc.identifier.otherOAK-24414*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/249385-
dc.description.abstractThree miR-34 family members (miR-34a, miR-34b, and miR-34c) are clustered on two different chromosomal loci, Mir34a and Mir34b/c. These miRNAs have identical seed sequences, which are predicted to target the same set of genes. However, miR-34a and miR-34c have different sets of negatively correlated genes in lung adenocarcinoma data from The Cancer Genome Atlas. Therefore, we hypothesized that the individual miR-34 family members, which are tumor suppressive miRNAs, would have varying effects on lung tumorigenesis. To show this, we overexpressed each miR-34 cluster in murine lung cancer cells. MiR-34b/c enhanced cancer cell attachment and suppressed cell growth and invasion compared with miR-34a. In a syngeneic mouse model, both miR-34a and miR-34b/c blocked lung metastasis. However, miR-34b/c suppressed tumor growth more than miR-34a. MiR-34b/c also decreased the expression of mesenchymal markers (Cdh2 and Fn1) and increased the expression of epithelial markers (Cldn3, Dsp, and miR-200) to a greater degree than miR-34a. These results imply that miR-34b and miR-34c inhibit epithelial-to-mesenchymal transition. Furthermore, knockout of all three miR-34 members promoted mutant Kras-driven lung tumor progression in mice. Similarly, lung adenocarcinoma patients with higher miR-34a/b/c levels had better survival rates than did those with lower levels. In summary, we suggest that miR-34b and miR-34c are more effective tumor suppressors than miR-34a.*
dc.languageEnglish*
dc.publisherNATURE PUBLISHING GROUP*
dc.titleMiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas*
dc.typeArticle*
dc.relation.volume51*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.indexKCI*
dc.relation.journaltitleEXPERIMENTAL AND MOLECULAR MEDICINE*
dc.identifier.doi10.1038/s12276-018-0203-1*
dc.identifier.wosidWOS:000460463400001*
dc.identifier.scopusid2-s2.0-85060937515*
dc.author.googleKim, Jeong Seon*
dc.author.googleKim, Eun Ju*
dc.author.googleLee, Sieun*
dc.author.googleTan, Xiaochao*
dc.author.googleLiu, Xin*
dc.author.googlePark, Sanghui*
dc.author.googleKang, Keunsoo*
dc.author.googleYoon, Jung-Sook*
dc.author.googleKo, Yoon Ho*
dc.author.googleKurie, Jonathan M.*
dc.author.googleAhn, Young-Ho*
dc.contributor.scopusid박상희(12041890800)*
dc.contributor.scopusid안영호(7202402440)*
dc.date.modifydate20240222132209*


qrcode

BROWSE